Form 8-K - Current report:
SEC Accession No. 0000950170-24-096191
Filing Date
2024-08-13
Accepted
2024-08-13 16:08:26
Documents
13
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20240813.htm   iXBRL 8-K 41056
2 EX-99.1 bolt-ex99_1.htm EX-99.1 264710
3 GRAPHIC img192637872_0.jpg GRAPHIC 3892
  Complete submission text file 0000950170-24-096191.txt   443973

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20240813.xsd EX-101.SCH 25968
15 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20240813_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 241201451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)